Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 1
2006 7
2007 10
2008 3
2009 3
2010 4
2011 2
2012 4
2013 3
2014 4
2015 6
2016 10
2017 12
2018 5
2019 5
2020 7
2021 4
2022 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Hsu WF, Lai HC, Chen CK, Wang HW, Chuang PH, Tsai MH, Chen SH, Chu CS, Su WP, Chou JW, Kao JT, Chen HY, Chuang SC, Tsai TY, Hsiao WD, Huang GT, Peng CY. Hsu WF, et al. Among authors: chen ck. Am J Cancer Res. 2023 Feb 15;13(2):654-668. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895987 Free PMC article.
An artificial intelligence system to predict the optimal timing for mechanical ventilation weaning for intensive care unit patients: A two-stage prediction approach.
Liu CF, Hung CM, Ko SC, Cheng KC, Chao CM, Sung MI, Hsing SC, Wang JJ, Chen CJ, Lai CC, Chen CM, Chiu CC. Liu CF, et al. Among authors: cheng kc. Front Med (Lausanne). 2022 Nov 18;9:935366. doi: 10.3389/fmed.2022.935366. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36465940 Free PMC article.
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.
Hsu WF, Wang HW, Chen CK, Lai HC, Chuang PH, Tsai MH, Su WP, Chen HY, Chu CS, Chou JW, Chen SH, Tsai TY, Hsiao WD, Lin CC, Huang GT, Lin JT, Peng CY. Hsu WF, et al. Among authors: chen ck. Am J Cancer Res. 2021 Dec 15;11(12):6173-6187. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018250 Free PMC article.
95 results